1. Home
  2. RDVT vs SPRY Comparison

RDVT vs SPRY Comparison

Compare RDVT & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Red Violet Inc.

RDVT

Red Violet Inc.

HOLD

Current Price

$69.28

Market Cap

793.2M

Sector

Technology

ML Signal

HOLD

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$8.26

Market Cap

796.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDVT
SPRY
Founded
2017
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
793.2M
796.4M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
RDVT
SPRY
Price
$69.28
$8.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$62.00
$40.00
AVG Volume (30 Days)
160.0K
1.9M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
82.00
N/A
EPS
0.30
N/A
Revenue
$90,252,000.00
$84,278,000.00
Revenue This Year
$16.31
$87.40
Revenue Next Year
$13.83
$81.64
P/E Ratio
$218.40
N/A
Revenue Growth
20.03
N/A
52 Week Low
$33.40
$6.66
52 Week High
$67.68
$18.63

Technical Indicators

Market Signals
Indicator
RDVT
SPRY
Relative Strength Index (RSI) 82.15 43.94
Support Level $50.66 $7.41
Resistance Level N/A $8.61
Average True Range (ATR) 2.66 0.58
MACD 0.97 -0.20
Stochastic Oscillator 96.04 22.25

Price Performance

Historical Comparison
RDVT
SPRY

About RDVT Red Violet Inc.

Red Violet Inc builds proprietary technologies and applies analytical capabilities to deliver identity intelligence. The company's solutions enable the real-time identification and location of people, businesses, assets, and their interrelationships. These solutions are used for purposes including identity verification, risk mitigation, due diligence, fraud detection and prevention, regulatory compliance, and customer acquisition. Its cloud-native, AI-enabled identity intelligence platform, CORE, is purpose-built for the enterprise, yet flexible enough for organizations of all sizes, bringing clarity to massive datasets by transforming data into intelligence. The company generates substantially all of its revenue from licensing its solutions.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

Share on Social Networks: